| Related Articles |
Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report.
Clin Psychopharmacol Neurosci. 2015 Dec 31;13(3):321-323
Authors: Ram D, Patil S, Gowdappa B, Rajalakshmi I
Abstract
Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam was added with sertraline, escitalopram, desvenlafaxin, she did not improve significantly until paroxetine was added. When clonazepam-paroxetine combination was added with propranolol, etizolam, olanzepine, risperidone and amisulpride the symptom remission did not occur until a trial of Atomoxetine was done.
PMID: 26598594 [PubMed – as supplied by publisher]
via http://www.ncbi.nlm.nih.gov/pubmed/26598594?dopt=Abstract
